Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

[Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Normal Morning MCH Levels and No Association with REM or NREM Sleep Parameters in Narcolepsy Type 1 and Type 2

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The angiotensin II type I receptor (AT1R) is involved in the regulation of cardiovascular function. Excessive activation of AT1R by angiotensin II (Ang II) leads to cardiovascular disease and may be involved in the development of insulin resistance and diabetes. Functionally selective Ang II analogues, such as the [Sar1, Ile4, Ile8]-angiotensin II (SII Ang II) analogue, that only activate a subset of signalling networks have been demonstrated to have beneficial effects on cardiovascular function in certain settings, including lowering blood pressure and increasing cardiac performance. Here, we studied the effect of SII Ang II on insulin receptor (IR) signalling and glucose metabolism in primary rat hepatocytes. We show that long-term pre-treatment of hepatocytes with SII Ang II increased insulin-stimulated glycogen synthesis, while Ang II and the AT1R antagonist losartan had no effect. Insulin-stimulated suppression of hepatic glucose output was not affected by Ang II or SII Ang II. It is well known that insulin regulates glycogen synthesis and glucose output through Akt-mediated phosphorylation of glycogen synthase kinase α/β (GSK3α/β) and forkhead box protein O1 (FOXO1), respectively. In line with this, we show that SII Ang II potentiated insulin-stimulated phosphorylation of Akt and GSK3α/β, but not FOXO1. Furthermore, we demonstrate that the effect of SII Ang II on insulin-stimulated signalling and glycogen synthesis was dependent on Src and Gαq, as inhibitors of these proteins abolished the potentiating effect of SII Ang II. Thus, our results demonstrate that SII Ang II may have a positive effect on IR signalling and glucose metabolism in hepatocytes.

Original languageEnglish
JournalBasic & clinical pharmacology & toxicology
Volume122
Issue number5
Pages (from-to)460-469
Number of pages10
ISSN1742-7843
DOIs
Publication statusPublished - May 2018

    Research areas

  • Angiotensin II/analogs & derivatives, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Energy Metabolism/drug effects, Glucose/metabolism, Glycogen/biosynthesis, Glycogen Synthase Kinase 3/metabolism, Glycogen Synthase Kinase 3 beta/metabolism, Hepatocytes/drug effects, Insulin/pharmacology, Male, Phosphorylation, Primary Cell Culture, Proto-Oncogene Proteins c-akt/metabolism, Rats, Sprague-Dawley, Receptor, Angiotensin, Type 1/agonists, Receptor, Insulin/agonists, Signal Transduction/drug effects, Time Factors

ID: 55709079